Authors: van de Loosdrecht, AA Kok, K de Vries, B van der Veen, AY van den Berg, E Esselink, MT Marynen, P Vellenga, E van Imhoff, GW

Citation: Aa. Van De Loosdrecht et al., Breakpoint analysis by fluorescence in situ hybridization in myelodysplastic syndromes with t(3;12)(q26;p13) and expression of EVI1, LEUKEMIA, 14(10), 2000, pp. 1857-1858

Authors: Birkenkamp, KU Esselink, MT Kruijer, W Vellenga, E

Citation: Ku. Birkenkamp et al., An inhibitor of PI3-K differentially affects proliferation and IL-6 protein secretion in normal and leukemic myeloid cells depending on the stage of differentiation, EXP HEMATOL, 28(11), 2000, pp. 1239-1249

Authors: Birkenkamp, KU Esselink, MT Kruijer, W Vellenga, E

Citation: Ku. Birkenkamp et al., Differential effects of interleukin-3 and interleukin-1 on the proliferation and interleukin-6 protein secretion of acute myeloid leukemic cells; theinvolvement of ERK, p38 and STAT5, EUR CYTOKIN, 10(4), 1999, pp. 479-490

Authors: Birkenkamp, KU Dokter, WHA Esselink, MT Jonk, LJC Kruijer, W Vellenga, E

Citation: Ku. Birkenkamp et al., A dual function for p38 MAP kinase in hematopoietic cells: involvement in apoptosis and cell activation, LEUKEMIA, 13(7), 1999, pp. 1037-1045

Authors: Borger, P Kauffman, HF Postma, DS Esselink, MT Vellenga, E

Citation: P. Borger et al., Interleukin-15 differentially enhances the expression of interferon-gamma and interleukin-4 in activated human (CD4(+))T lymphocytes, IMMUNOLOGY, 96(2), 1999, pp. 207-214